Rapid desensitization of muscarinic m3 receptor-stimulated polyphosphoinositide responses. 1992

A B Tobin, and D G Lambert, and S R Nahorski
University of Leicester, Department of Pharmacology and Therapeutics, UK.

Chinese hamster ovary (CHO) cells transfected with human m3 muscarinic receptor cDNA (Bmax, 1343 +/- 46.8 fmol/mg of protein) were used to investigate agonist-mediated muscarinic receptor desensitization. Stimulation of CHO-m3 cells with a maximal dose of carbachol resulted in a biphasic production of mass inositol-1,4,5-trisphosphate [Ins(1,4,5)P3], measured by radioreceptor binding assay. The first phase comprises a rapid 8-10-fold increase in Ins(1,4,5)P3 that peaks after 10 sec and falls to levels 3-4-fold over basal within 1 min Ins(1,4,5)P3 rises again over the next 20 min to approximately 8-10-fold above basal, where levels are sustained for at least 2 hr. This later phase is, therefore, considered to be a desensitization-resistant component of m3 receptor activation. A 5-min pre-exposure of CHO-m3 cells to carbachol resulted in attenuation of the initial peak Ins(1,4,5)P3 response to a subsequent application of agonist. The attenuation of the Ins(1,4,5)P3 response was reversible with a t1/2 of approximately 7.5 min. Desensitization and recovery of the peak Ins(1,4,5)P3 response correlated with a decrease and subsequent recovery of m3 receptor-mediated mobilization of intracellular calcium stores, suggesting that the consequence of peak Ins(1,4,5)P3 desensitization is a reduced calcium mobilization response. N-[3H]Methylscopolamine binding to intact cells revealed that there was no change in cell surface m3 receptors during the 5-min pre-exposure to agonist, indicating that the mechanism of muscarinic receptor desensitization described here is not sequestration or internalization of receptors.

UI MeSH Term Description Entries
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D002217 Carbachol A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS. Carbamylcholine,Carbacholine,Carbamann,Carbamoylcholine,Carbastat,Carbocholine,Carboptic,Doryl,Isopto Carbachol,Jestryl,Miostat,Carbachol, Isopto
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012602 Scopolamine Derivatives Analogs or derivatives of scopolamine. Scopolamines,Derivatives, Scopolamine
D015544 Inositol 1,4,5-Trisphosphate Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cell's endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin. 1,4,5-InsP3,Inositol 1,4,5-Triphosphate,Myo-Inositol 1,4,5-Trisphosphate,1,4,5-IP3,Myoinositol 1,4,5-Triphosphate
D016466 CHO Cells CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus (CRICETULUS). The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells. CHO Cell,Cell, CHO,Cells, CHO
D019832 N-Methylscopolamine A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors. DD-234,Hyoscine Methiodide,Hyoscine Methobromide,Methscopolamine,Methylscopolamine Nitrate,Methylscopolammonium Methylsulfate,N-Methylscine Methylsulfate,N-Methylscopolamine Bromide,N-Methylscopolamine Iodide,N-Methylscopolamine Methylchloride,N-Methylscopolamine Methylsulfate,N-Methylscopolamine Nitrate,Scopolamine Methylbromide,Skopyl,Ulix,Bromide, N-Methylscopolamine,DD 234,DD234,Iodide, N-Methylscopolamine,Methiodide, Hyoscine,Methobromide, Hyoscine,Methylbromide, Scopolamine,Methylchloride, N-Methylscopolamine,Methylsulfate, Methylscopolammonium,Methylsulfate, N-Methylscine,Methylsulfate, N-Methylscopolamine,N Methylscine Methylsulfate,N Methylscopolamine,N Methylscopolamine Bromide,N Methylscopolamine Iodide,N Methylscopolamine Methylchloride,N Methylscopolamine Methylsulfate,N Methylscopolamine Nitrate,Nitrate, Methylscopolamine,Nitrate, N-Methylscopolamine

Related Publications

A B Tobin, and D G Lambert, and S R Nahorski
January 1990, Neurochemistry international,
A B Tobin, and D G Lambert, and S R Nahorski
September 2006, Expert opinion on therapeutic patents,
A B Tobin, and D G Lambert, and S R Nahorski
September 2006, Expert opinion on therapeutic patents,
A B Tobin, and D G Lambert, and S R Nahorski
January 1997, Life sciences,
A B Tobin, and D G Lambert, and S R Nahorski
September 1994, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
A B Tobin, and D G Lambert, and S R Nahorski
November 1994, Neuroscience,
A B Tobin, and D G Lambert, and S R Nahorski
September 1994, Molecular pharmacology,
A B Tobin, and D G Lambert, and S R Nahorski
August 1992, Gastroenterologia Japonica,
A B Tobin, and D G Lambert, and S R Nahorski
January 2022, Frontiers in pharmacology,
Copied contents to your clipboard!